1. Home
  2. DARE vs SWAG Comparison

DARE vs SWAG Comparison

Compare DARE & SWAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • SWAG
  • Stock Information
  • Founded
  • DARE 2015
  • SWAG 1994
  • Country
  • DARE United States
  • SWAG United States
  • Employees
  • DARE N/A
  • SWAG N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • SWAG Advertising
  • Sector
  • DARE Health Care
  • SWAG Consumer Discretionary
  • Exchange
  • DARE Nasdaq
  • SWAG Nasdaq
  • Market Cap
  • DARE 28.0M
  • SWAG 30.4M
  • IPO Year
  • DARE N/A
  • SWAG 2021
  • Fundamental
  • Price
  • DARE $2.10
  • SWAG $1.90
  • Analyst Decision
  • DARE Strong Buy
  • SWAG
  • Analyst Count
  • DARE 2
  • SWAG 0
  • Target Price
  • DARE $10.00
  • SWAG N/A
  • AVG Volume (30 Days)
  • DARE 124.8K
  • SWAG 128.4K
  • Earning Date
  • DARE 11-13-2025
  • SWAG 11-06-2025
  • Dividend Yield
  • DARE N/A
  • SWAG N/A
  • EPS Growth
  • DARE N/A
  • SWAG N/A
  • EPS
  • DARE N/A
  • SWAG N/A
  • Revenue
  • DARE N/A
  • SWAG $108,405,000.00
  • Revenue This Year
  • DARE $6,864.02
  • SWAG N/A
  • Revenue Next Year
  • DARE $4,922.46
  • SWAG N/A
  • P/E Ratio
  • DARE N/A
  • SWAG N/A
  • Revenue Growth
  • DARE N/A
  • SWAG 38.74
  • 52 Week Low
  • DARE $1.83
  • SWAG $0.73
  • 52 Week High
  • DARE $9.19
  • SWAG $1.96
  • Technical
  • Relative Strength Index (RSI)
  • DARE 51.03
  • SWAG 63.52
  • Support Level
  • DARE N/A
  • SWAG $1.79
  • Resistance Level
  • DARE $2.15
  • SWAG $1.96
  • Average True Range (ATR)
  • DARE 0.07
  • SWAG 0.09
  • MACD
  • DARE -0.06
  • SWAG 0.01
  • Stochastic Oscillator
  • DARE 95.53
  • SWAG 83.78

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About SWAG Stran & Company Inc.

Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. In addition to selling branded products, it offers its clients custom sourcing capabilities, which is a flexible and customizable e-commerce solution for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral, event assets, order and inventory management, and designing and hosting online retail pop-up shops. The company's segment consists of the Stran segment and the SLS segment. The company generates the majority of its revenue from the Stran segment.

Share on Social Networks: